-
公开(公告)号:JPH01308270A
公开(公告)日:1989-12-12
申请号:JP13795688
申请日:1988-06-03
Applicant: FUJISAWA PHARMACEUTICAL CO
Inventor: MUKUDA TAKASHI , UEMATSU RYOICHI , HIRABAYASHI SATOSHI
IPC: C07D285/08
Abstract: PURPOSE:To obtain the title compound useful as a synthetic raw material for beta-lactam based antibiotic in one process, high yield and low cost, by reacting formamidine, or salt thereof with a xanthic acid O-ester and sulfur using the above-mentioned compounds as raw materials. CONSTITUTION:Formamidine or salt thereof is reacted with xanthic acid O-ester or salt thereof and sulfur normally in a solvent such as water, acetone or chloroform at ambient temperature or while heating to provide the aimed compound. The xanthic acid O-ester includes O-alkylxanthic acid such as O-methylxanthic acid, especially preferably 1-6C alkylxanthic acid. Further, the xanthic acid O-ester and salt thereof can be readily synthesized from carbon disulfide and alcoholic base and can be reacted with formamidine after isolating or without isolating.
-
公开(公告)号:JPH0318609B2
公开(公告)日:1991-03-13
申请号:JP16282282
申请日:1982-09-18
Applicant: FUJISAWA PHARMACEUTICAL CO
Inventor: YAZAWA HISATOYO , MUKUDA TAKASHI , KONO KEIKO
IPC: C07D501/06 , C07C67/00 , C07C231/00 , C07C231/02 , C07C233/02 , C07C233/07 , C07D257/04 , C07K1/10
-
公开(公告)号:JPH0625102B2
公开(公告)日:1994-04-06
申请号:JP12218791
申请日:1991-04-23
Applicant: FUJISAWA PHARMACEUTICAL CO
Inventor: ZANKA ATSUHIKO , MUKUDA TAKASHI , HIRABAYASHI SATOSHI
IPC: C07C303/38 , A61K31/18 , C07C20060101 , C07C43/257 , C07C303/40 , C07C311/08 , C07C311/09 , C07C319/06 , C07C319/18 , C07C323/09 , C07C323/37 , C07C323/49 , C07C323/63
-
公开(公告)号:JPH04312559A
公开(公告)日:1992-11-04
申请号:JP10664491
申请日:1991-04-10
Applicant: FUJISAWA PHARMACEUTICAL CO
Inventor: ZANKA ATSUHIKO , HIRABAYASHI SATOSHI , MUKUDA TAKASHI , KUBOTA ARIKATSU
IPC: C07C221/00 , C07C225/22
Abstract: PURPOSE:To industrially and advantageously obtain 4-alkanoyl-2-haloanilines useful as an intermediate for alkanesulfonanilide derivatives having pharmacological actions such as anti-inflammatory and analgesic actions by using a stable halogenating reagent. CONSTITUTION:A 4-alkanoylaniline or its salt is reacted with an N- halosuccinimide stable to heat, shock, etc., in the presence of an aromatic amine according to a conventional method to selectively halogenate the 2-position of the 4-alkanoylaniline. Thereby, the objective 4-alkanoyl-2-haloaniline or its salt is industrially and advantageously obtained.
-
公开(公告)号:JP2000080072A
公开(公告)日:2000-03-21
申请号:JP18860599
申请日:1999-07-02
Applicant: FUJISAWA PHARMACEUTICAL CO
Inventor: MUKAI KOJI , MUKUDA TAKASHI , KAWAKAMI RYOICHI
IPC: C07C277/08 , C07C279/14
Abstract: PROBLEM TO BE SOLVED: To obtain L-arginine having a small crystal particle size distribution width in good particle size distribution repeatability and suitable for powder filling treatments by adding a specific amount of L-arginine crystals as seed crystals to a supersaturated solution of the L-arginine, when the L-arginine is crystallized. SOLUTION: This method for producing arginine crystals comprises crystallizing L-arginine. Therein, L-arginine crystals are added as seed crystals to the supersaturated solution of the L-arginine. The L-arginine crystals use for the seed crystals are preferably particulate L-arginine which has an average particle diameter of 100-300 μm and to which many fine L-arginine crystals (preferably fine L-arginine crystals having a particle diameter of 0.5-2 μm in an amount of 1×109 to 1×1011 crystals/g of the seed crystals) are preferably adhered as secondary nuclei used as the crystallization of the L-arginine. The L-arginine crystals used as the seed crystals may be fine L-arginine crystals obtained by grinding L-arginine crystals by the use of a grinder, etc., and having a particle diameter of 0.5-2 μm.
-
公开(公告)号:JPH064640B2
公开(公告)日:1994-01-19
申请号:JP13245684
申请日:1984-06-26
Applicant: FUJISAWA PHARMACEUTICAL CO
Inventor: YAZAWA HISATOYO , ICHIHARA MASAHARU , KAGARA KOJI , MUKUDA TAKASHI
IPC: C07D501/04
-
公开(公告)号:JPH051023A
公开(公告)日:1993-01-08
申请号:JP12218791
申请日:1991-04-23
Applicant: FUJISAWA PHARMACEUTICAL CO
Inventor: ZANKA ATSUHIKO , MUKUDA TAKASHI , HIRABAYASHI SATOSHI
IPC: C07C303/38 , A61K31/18 , C07C20060101 , C07C43/257 , C07C303/40 , C07C311/08 , C07C311/09 , C07C319/06 , C07C319/18 , C07C323/09 , C07C323/37 , C07C323/49 , C07C323/63
Abstract: PURPOSE:To produce an alkanesulfoneanilide derivative or salt thereof having antiphlogistic action and analgesic action from a new raw material, in reduced producing processes and good yield. CONSTITUTION:A new compound expressed by formula I (R is lower alkyl; R is CN, CONH2 or lower alkanoyl; X is halogen) or salt thereof is reacted with a compound expressed by formula II (R and R are halogen; A is O or S; M is H, alkali metal or Cu) or salt thereof in the presence of a copper-base catalyst and a base using an aromatic amine based solvent to directly provide a compound expressed by formula III or salt thereof in high yield without using a preliminary process required in a conventional method. Furthermore, the new above-mentioned raw material can be produced by reacting a compound expressed by formula IV, its reactive derivative of the amino group or salt thereof with a compound expressed by the formula R SO2OH, its reactive derivative of the sulfonic acid group or salt thereof to give a compound expressed by formula V or salt thereof and then hologenating the compound expressed by formula V or salt thereof.
-
-
-
-
-
-